Eaton Vance Management Apellis Pharmaceuticals, Inc. Transaction History
Eaton Vance Management
- $67.5 Billion
- Q3 2022
A detailed history of Eaton Vance Management transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Eaton Vance Management holds 50,324 shares of APLS stock, worth $1.45 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
50,324
Previous 50,424
0.2%
Holding current value
$1.45 Million
Previous $2.28 Million
50.68%
% of portfolio
0.01%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding APLS
# of Institutions
299Shares Held
113MCall Options Held
5.21MPut Options Held
691K-
Wellington Management Group LLP Boston, MA16.4MShares$473 Million0.11% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.6MShares$335 Million15.74% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$320 Million5.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.81MShares$283 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.8MShares$167 Million0.01% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $3.17B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...